TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Anxiety symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Patients Who Experience Asthma Related Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Development of refeeding syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Significant electrolyte disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decision Conflict Scale (DCS) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood draw values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of eligible participants out of screened participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success rate of obtaining consent from those eligible participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total number of adverse events reported by the participants using their workbook
Endpoint domain: Adverse events/effects
Primary endpoint: Change in IBS-Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change from baseline health insurance literacy to 5-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Satisfaction Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent of Participants with High Satisfaction Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: expression of ZEB1 protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of Eligible Patients who decline consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Participants who miss or refuse ePROMs follow-ups
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of Enrolled Patients who Drop-Out From the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall response rate of chronic GvHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in weekly average of momentary pain self-reports
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful delivery of radio-opaque media
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major adverse cardiovascular events (MACEs) and stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative number of subjects without positive PLE reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Correct Responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in Errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: major pathological response (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline in the Fugl-Meyer Assessment for Upper Extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized skin surface biopsy technique effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients with ACLF grade <2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCT time in tumor patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response to at-home upper-extremity BCI rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quality of life rating on the Subjective Quality of Life Questionnaire (SQoL) at Week 8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in depression on the Spinal Cord Injury Quality of Life Measurement System-Depression Short Form at Week 8
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in pain interference on the Spinal Cord Injury Quality of Life - Measurement System-Pain Interference Short Form at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Total Health Score (THS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total number of doses of rescue medication for breakthrough pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Drug Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Change in family cohesion
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in parents' setting clear, firm rules against youth substance use
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in parental supervision of children
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in youth attitude favorable to alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of additional information
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of applicant decline
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retained gastric contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NSAID/Acetaminophen use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Norco 5/325 (Hydrocone-Acetaminophen) Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of Body Dysmorphic Disorder (BDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fNIRS after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in remission rate of HAM-D24 score after treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall rate of maternal-fetal transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Response rate of ASAS20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of the stent during the first 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Assessment of adverse events through 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: Heart-related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional recovery (level of disability)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of children prescribed an antibiotic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety and tolerability of JS006
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose of JS006
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase II dose for JS006
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to convergence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak extension timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak flexion timing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Largest lyapunov exponent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Invasive mechanical ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expectations regarding knowledge and communication with health professionals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mortality ratio
Endpoint domain: Mortality/survival
Primary endpoint: estimated maximum oxygen consumption (eVO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-time sit-to-stand duration (second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical component score (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Blood concentrations of vitamins and trace elements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain Beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with confirmed composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with composite bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Change of serum HBsAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disappearance of pain related to anal fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDNF serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Lower Eyelid Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateralization Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Palpebral Fissure Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of leaks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (All Causalities)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (Treatment Related)
Endpoint domain: Adverse events/effects
Primary endpoint: Participant engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of corneal collagen CXL for treating refractory corneal ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar ridge bucco-lingual width change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proportion of low-risk actinic keratosis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in ovarian endometrioma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recession change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mass balance and total recovery of [14C]-radioactivity in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mass balance and total recovery of [14C]-radioactivity in faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC0-∞ for [14C]BI 1810631
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal String Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ability to perform test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in self-reported alcohol-related sexual behavior frequency
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in self-reported alcohol-related sexual behavior quantity
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in self-reported alcohol-related hook-ups
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in self-reported alcohol-related sexual behavior consequences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HRPR risk
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Level Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Burden
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean in left ventricule myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean in Kidney acetate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean in Kidney acetoacetate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall performance on test 2
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Body composition (% of fat mass and % of non-fat mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid profile serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overweight and obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of mortality, intubation, or noninvasive ventilation failure
Endpoint domain: Mortality/survival
Primary endpoint: Material consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Working time expenditure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Comfort satisfaction while wearing contact lenses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in Weight-for-Length Z-score (WLZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Short performance physical battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve from Hour 0 to the Last Measurable Concentration (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration from Hour 0 Extrapolated to Infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of the Posttraumatic Stress Disorder score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of the Rapid Eye Movement Behavior Disorder symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIPE Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Radiographic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of documented wound complication
Endpoint domain: Adverse events/effects
Primary endpoint: Cure rate for bronchopleural fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of metabolomics features for assessing portal hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of subjects with tumor associated antigens expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: iAUC of SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of grade ≥2 diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade ≥3 neutropenia
Endpoint domain: Adverse events/effects
Primary endpoint: Ketone Body Turnover (ketogenesis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Norepinephrine turnover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Menstrual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic bone defect fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PTSD Symptom Scores from Baseline to Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Average RESIDUAL Limb Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Average PHANTOM Limb Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Impression of Change for RESIDUAL Limb Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Global Impression of Change for PHANTOM Limb Pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete Response Rate (CRR) as Assessed by an Independent Review Committee (IRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Early Warning Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deep sternal wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of superficial sternal wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of wound dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: Movement Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scores obtained in FactCOG
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in vastus lateralis fiber cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in quadriceps strength via 3 repetition maximum testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in quadriceps strength via isokinetic dynamometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maxillary sinus linear measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maxillary sinus volumetric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of resident handling in Bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of resident handling in Wheelchair - Sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving a 90% reduction in PASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence of dysfunctions in social cognition
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Erythrocyte NO synthase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Erythrocyte-mediated NO release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of hospital-acquired infections
Endpoint domain: Adverse events/effects
Primary endpoint: CTCs viability evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenated hemoglobin (HbO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal Cognitive Assessment (MoCA) test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EN value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of serious adverse device and procedure related effects
Endpoint domain: Adverse events/effects
Primary endpoint: Complications associated with gestational diabetes mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with IRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of long bone deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Difference in rate of sodium glucose co-transporter 2 inhibitors (SGLT2i)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Microbiome functional gene capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total resistance rate under CC for ovulation induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100 meter timed test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: North Star assessment for limb girdle type dystrophies (NSAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4 stair climb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of Upper Limb (PUL) 2.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimum time for intravenous cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of subjects with worsened symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative Nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Side Effects
Endpoint domain: Adverse events/effects